Phospholipase A2 group IIA is elevated in endometriomas but not in peritoneal fluid and serum of ovarian endometriosis patients.

Kocbek, Vida; Bersinger, Nick A.; Brglez, Vesna; Mueller, Michael; Petan, Toni; Rižner, Tea Lanišnik (2015). Phospholipase A2 group IIA is elevated in endometriomas but not in peritoneal fluid and serum of ovarian endometriosis patients. Gynecological endocrinology, 31(3), pp. 214-218. Informa Healthcare 10.3109/09513590.2014.975690

Full text not available from this repository. (Request a copy)

Our previous gene expression analysis identified phospholipase A2 group IIA (PLA2G2A) as a potential biomarker of ovarian endometriosis. The aim of this study was to evaluate PLA2G2A mRNA and protein levels in tissue samples (endometriomas and normal endometrium) and in serum and peritoneal fluid of ovarian endometriosis patients and control women. One-hundred and sixteen women were included in this study: the case group included 70 ovarian endometriosis patients, and the control group included 38 healthy women and 8 patients with benign ovarian cysts. We observed 41.6-fold greater PLA2G2A mRNA levels in endometrioma tissue, compared to normal endometrium tissue. Using Western blotting, PLA2G2A was detected in all samples of endometriomas, but not in normal endometrium, and immunohistochemistry showed PLA2G2A-specific staining in epithelial cells of endometrioma paraffin sections. However, there were no significant differences in PLA2G2A levels between cases and controls according to ELISA of peritoneal fluid (6.0 ± 4.4 ng/ml, 6.6 ± 4.3 ng/ml; p = 0.5240) and serum (2.9 ± 2.1 ng/ml, 3.1 ± 2.2 ng/ml; p = 0.7989). Our data indicate that PLA2G2A is implicated in the pathophysiology of ovarian endometriosis, but that it cannot be used as a diagnostic biomarker.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Endometriose und gynäkologische Onkologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Endometriose und gynäkologische Onkologie

UniBE Contributor:

Kocbek, Vida, Bersinger, Nick A., Mueller, Michael

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0951-3590

Publisher:

Informa Healthcare

Language:

English

Submitter:

Monika Zehr

Date Deposited:

10 Jul 2015 09:25

Last Modified:

05 Dec 2022 14:48

Publisher DOI:

10.3109/09513590.2014.975690

PubMed ID:

25366587

Uncontrolled Keywords:

Biomarkers; PLA2G2A; inflammation; ovarian endometriosis

URI:

https://boris.unibe.ch/id/eprint/69832

Actions (login required)

Edit item Edit item
Provide Feedback